Team Maureen

instagram

Head & Neck Cancer

FDA Expands Gardasil 9 Indication

The FDA has approved an expanded indication for Gardasil 9 for the prevention of oropharyngeal and other head and neck cancers caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58, according to Merck, the developer of the HPV 9-valent recombinant vaccine.1

updated: 4 months ago